Abstract:Objective To evaluate the impact of different treatment strategies on patients with hepatocellular carcinoma (HCC) of less than 10 cm but with portal vein tumor thrombus (PVTT),and to investigate the prognostic factors.Methods Between 2003 and 2008,338 HCC patients with PVTT from the Affiliated Tumor Hospital,Guangxi Medical University,were retrospectively studied.These patients were divided into four groups:the conservative treatment group (n =75),the transarterial chemoembolization (TACE) group (n=86),the surgical resection group (n =90) and the surgical resection with postoperative TACE group (n=87).Survival rates were analyzed by the Kaplan-Meier method and differences among groups were compared using the log-rank analysis.The Cox' s proportional hazards model was performed to explore the risk factors of survival.Results The mean survival periods of patients in the four groups were 3.8,7,8.2,15.1 months respectively.There were significant differences in survival rate among the 4 groups.The survival rates at 1-,2-,and 3-year in the surgical resection with postoperative TACE group were 49％,37％ and 19％,which were significantly higher than the other 3 groups (P＜0.05).The 1-,2-,and 3-year survival rates in the surgical resection group were 28％,20％ and 15％ compared with 17.5％,0％ and 0％ in the TACE group.The survival rates were significantly higher after surgical resection than TACE (P＜0.05).The 1-,2-,and 3-year survival rates in the conservative treatment group were 0％.These were the lowest among the four groups (P＜0.05).Univariate analysis indicated that portal vein occlusion by tumor thrombus was a significant predictor of poor prognosis.Multivariate analysis revealed that the strategy of treatment (TACE) and the number of TACE cycles were independent survival predictors for HCC patients with PVTT.Conclusions Surgical resection is the most effective therapeutic strategy for HCC patients with PVTT and with good liver functional reserve.Postoperative TACE is necessary in preventing recurrence and prolonging survival in patients who could tolerate chemoembolization.TACE should be recommended as an effective and safe treatment for unresectable HCC patients with PVTT.The treatment provided a significantly better survival than conservative treatment.

[Time Dependency of Factors Influencing Survival of Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis after Surgery].

Factors Influencing Survival in Hepatocellular Carcinoma Patients with Macroscopic Portal Vein Tumor Thrombosis after Surgery, with Special Reference to Time Dependency: a Single-Center Experience of 381 Cases.

Influencing Factors for Prognosis of Patients with Hepatocellular Carcinoma Complicated with Portal Vein Tumor Thrombus after Surgical Treatment

Efficacy of Different Treatment Strategies for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

A Retrospective Study on Two Surgical Techniques in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and to Determine the Prognostic Factors of Overall Survival

Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study

[The Effects of Portal Vein Microscopic and Macroscopic Tumor Thrombi on Post-Operation Patients with Hepatocellular Carcinoma].

Clinicopathologic characteristics and surgical outcomes of hepatocellular carcinoma with portal vein tumor thrombosis.

Surgical Treatment for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Surgical therapy and prognostic analysis for patients of terminal hepatocellular carcinoma with portal vein thrombus

Surgical Strategy For Hepatocellular Carcinoma Patients With Portal/Hepatic Vein Tumor Thrombosis

[Hepatic Resection with Removal of Tumor Thrombi for Hepatocellular Carcinoma with Tumor Thrombi in Portal Vein and Curative Analysis].

A Prognosis Model For Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombus Following Hepatic Resection

The Impact of Portal Vein Tumor Thrombus on Long-Term Survival after Liver Resection for Primary Hepatic Malignancy

[Comparison of the Results and Therapies for Hepatocellular Carcinoma with Tumor Thrombosis in Portal Vein].

Impact of treatment strategies on patients with hepatocellular carcinoma of less than 10 cm but with portal vein tumor thrombus

Clinicopathological Predictors of Poor Survival and Recurrence After Curative Resection in Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis

Therapeutic effects analysis of sixty-three cases of hepatocellular carcinoma with portal vein tumor thrombus

Surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus

Prognostic Analysis for Treatment Modalities in Hepatocellular Carcinomas with Portal Vein Tumor Thrombi.

Hepatocellular Carcinoma Associated with Tumor Thrombosis in the Portal Vein: the Effects of Different Treatments.